Main menu button

News

Analysis Gunnebo: Better without France
16 jan 2019
Analysis Gunnebo: Better without France
Equity Research
SJR acquires Women Executive Search
08 jan 2019
SJR acquires Women Executive Search
Deal News
SJR acquires Women Executive Search
08 jan 2019
SJR acquires Women Executive Search
Deal News
Symplify acquires SiteGainer
08 jan 2019
Symplify acquires SiteGainer
Deal News
Symplify acquires SiteGainer
08 jan 2019
Symplify acquires SiteGainer
Deal News
Cicero Fonder acquires Aktieinvest Fonder
08 jan 2019
Cicero Fonder acquires Aktieinvest Fonder
Deal News
Cicero Fonder acquires Aktieinvest Fonder
08 jan 2019
Cicero Fonder acquires Aktieinvest Fonder
Deal News
Pareto Securities acquires Aktieinvest FK
08 jan 2019
Pareto Securities acquires Aktieinvest FK
Deal News
Pareto Securities acquires Aktieinvest FK
08 jan 2019
Pareto Securities acquires Aktieinvest FK
Deal News
Analysis, Annexin: Reduced visibility
07 jan 2019
Analysis, Annexin: Reduced visibility
Equity Research
Analysis, Saniona: Obestity treatment punches its weight
19 dec 2018
Analysis, Saniona: Obestity treatment punches its weight
Equity Research
Analysis Consilium: Turn-around on its way
14 dec 2018
Analysis Consilium: Turn-around on its way
Equity Research
Analysis, Biovica: Targets FDA clearance in 2020
14 dec 2018
Analysis, Biovica: Targets FDA clearance in 2020
Equity Research
Analysis TEO: Can only get better from here...
14 dec 2018
Analysis TEO: Can only get better from here...
Equity Research
Analysis FrontOffice: Turnaround case and Fintech in focus
07 dec 2018
Analysis FrontOffice: Turnaround case and Fintech in focus
Equity Research
Analysis Bublar: The next big game studio from Sweden?
05 dec 2018
Analysis Bublar: The next big game studio from Sweden?
Equity Research
Analysis, Nuevolution: Early projects showing strength
04 dec 2018
Analysis, Nuevolution: Early projects showing strength
Equity Research
Analysis, Svenska Aerogel: According to plan
29 nov 2018
Analysis, Svenska Aerogel: According to plan
Equity Research
Analysis, Brighter: In waiting mode
29 nov 2018
Analysis, Brighter: In waiting mode
Equity Research
Analysis, NeuroVive: Orphan drug portfolio growing up
27 nov 2018
Analysis, NeuroVive: Orphan drug portfolio growing up
Equity Research